EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial UQCRC2 as a Redox-Regulatory Node in Metabolic and Cardiometabolic Diseases

Shiyi Chen, Yang Jiao, Wen Shen iD, Xingru Hu, Guoyue Yuan, Jue Jia iD

Antioxidants · 25.06.2026 · 15 (7) · 794

DOI: 10.3390/antiox15070794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 25.06.2026. Verfasst von Shiyi Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Social Development Project of Jiangsu Province, Natural Science Foundation of Jiangsu Province, sixth phase 333 s level talent training project of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic and cardiometabolic diseases are closely associated with mitochondrial dysfunction and redox imbalance. Ubiquinol–cytochrome c reductase core protein 2 (UQCRC2), a non-catalytic structural core subunit of mitochondrial respiratory chain Complex III, is increasingly recognized as a regulator of Complex III integrity, electron transfer, oxidative phosphorylation, and mitochondrial redox homeostasis. Under metabolic stress, reduced expression or functional impairment of UQCRC2 may promote electron leakage, mitochondrial reactive oxygen species (mtROS) generation, lipid peroxidation, impaired antioxidant defense, and disrupted glucose–lipid metabolism. These alterations may contribute to insulin resistance (IR), metabolic dysfunction-associated steatotic liver disease (MASLD), obesity, and cardiovascular disease (CVD). This review summarizes current evidence linking UQCRC2 dysfunction to mitochondrial bioenergetic failure, oxidative stress, inflammatory signaling, and cardiometabolic injury. We further discuss redox-regulatory pathways, including Nrf2, AMPK–SIRT1–PGC-1α, glutathione metabolism, and mitophagy, as well as pharmacological agents and natural compounds that may modulate UQCRC2-related mitochondrial responses. Collectively, these findings highlight UQCRC2 as a redox-sensitive mitochondrial node linking Complex III dysfunction to cardiometabolic injury and targeted redox-based interventions.

Schlagwörter

Stichwörter der Autor:innen

UQCRC2complex IIIinsulin resistancemitochondrial ROSoxidative stressredox imbalance

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China.
  • Institute of Endocrine and Metabolic Diseases, Jiangsu University, Zhenjiang 212001, China.

ORCID-Profile: Wen Shen, Jue Jia

Förderung

  • Social Development Project of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province
  • sixth phase 333 s level talent training project of Jiangsu Province
  • Scientific Research Project of Jiangsu Provincial Health Commission
  • Traditional Chinese Medicine Science and Technology Development Plan Project of Jiangsu Province

Zitieren

APA

Chen, S., Jiao, Y., Shen, W., Hu, X., Yuan, G., & Jia, J. (2026). Mitochondrial UQCRC2 as a Redox-Regulatory Node in Metabolic and Cardiometabolic Diseases. Antioxidants, 15(7), 794. https://doi.org/10.3390/antiox15070794

Vancouver

Chen S, Jiao Y, Shen W, Hu X, Yuan G, Jia J. Mitochondrial UQCRC2 as a Redox-Regulatory Node in Metabolic and Cardiometabolic Diseases. Antioxidants. 2026;15(7):794. doi:10.3390/antiox15070794

BibTeX
@article{Chen2026,
  author = {Chen, Shiyi and Jiao, Yang and Shen, Wen and Hu, Xingru and Yuan, Guoyue and Jia, Jue},
  title = {Mitochondrial UQCRC2 as a Redox-Regulatory Node in Metabolic and Cardiometabolic Diseases},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {794},
  doi = {10.3390/antiox15070794}
}
Kostenlos starten →